Sybil Fisher, DPM
Podiatrist · Houston, TXNPI 1558338848
Payments from drug & device makers
Across 85 payments — averaging $42.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$954
- Paratek Pharmaceuticals, Inc.$739
- Treace Medical Concepts, Inc.$483
- Melinta Therapeutics, LLC$314
- AbbVie$160
- Anika Therapeutics, Inc.$155
- plus $765 from 14 others
What the payments were for
- Travel & lodging$97927%
- Food & beverage$2,59273%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 7 | $954 |
| Paratek Pharmaceuticals, Inc. | 23 | $739 |
| Treace Medical Concepts, Inc. | 8 | $483 |
| Melinta Therapeutics, LLC | 13 | $314 |
| AbbVie | 8 | $160 |
| Anika Therapeutics, Inc. | 1 | $155 |
| Amgen(2 entities) | 8 | $147 |
| Bone Support Inc. | 1 | $135 |
| Stryker | 1 | $101 |
| Abbott | 3 | $88 |
| Johnson & Johnson | 1 | $69 |
| Organogenesis Inc. | 2 | $49 |
| Heron Therapeutics, Inc. | 1 | $34 |
| Sebela Pharmaceuticals Inc. | 2 | $32 |
| Zimmer Biomet | 1 | $26 |
| Smith+Nephew | 1 | $21 |
| Medtronic | 1 | $19 |
| KCI USA, Inc. | 1 | $16 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $16 |
| Advanced Oxygen Therapy Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$357
- NUZYRA$333
- Integrity implant$155
- TACTOSET$155
- HYALOFAST$155
- CERAMENTBONE VOID FILLER$135
- Kimyrsa$117
- ALLOWRAP$101
How this compares
$3,570 in reported general payments places this provider in the 60th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 37 | $1,121 |
| CiclopiroxCiclopirox Olamine | 90 | $992 |
| Ammonium Lactate | 34 | $864 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $593 |
| Terbinafine Hcl | 21 | $454 |
| Clotrimazole | 22 | $360 |
| Econazole Nitrate | 11 | $138 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Houston
- Gary LepowHouston$1M
- Andrew SchneiderHouston$179K
- Gabriel MaislosHouston$140K
- Randall BeckmanHouston$104K
- Jason ArmstrongHouston$91K
- Smitha ManthaHouston$69K
- Jerry MilesHouston$58K
- Tina OliverHouston$42K
- Lawrence MactavishHouston$41K
- Roberto de Los SantosHouston$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.